Commonwealth Equity Services’s Antares Pharma, Inc. ATRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-45,582
| Closed | -$186K | – | 3855 |
|
|
2022
Q1 | $186K | Sell |
45,582
-1,100
| -2% | -$3.99K | ﹤0.01% | 3361 |
|
|
2021
Q4 | $166K | Sell |
46,682
-5,516
| -11% | -$19.3K | ﹤0.01% | 3354 |
|
|
2021
Q3 | $190K | Sell |
52,198
-1,406
| -3% | -$5.68K | ﹤0.01% | 3293 |
|
|
2021
Q2 | $233K | Sell |
53,604
-2,600
| -5% | -$10.6K | ﹤0.01% | 3137 |
|
|
2021
Q1 | $231K | Sell |
56,204
-7,465
| -12% | -$32.3K | ﹤0.01% | 3008 |
|
|
2020
Q4 | $254K | Buy |
63,669
+776
| +1% | +$2.51K | ﹤0.01% | 2717 |
|
|
2020
Q3 | $169K | Buy |
62,893
+400
| +0.6% | +$1.11K | ﹤0.01% | 2779 |
|
|
2020
Q2 | $171K | Buy |
62,493
+10,300
| +20% | +$28.7K | ﹤0.01% | 2664 |
|
|
2020
Q1 | $123K | Buy |
52,193
+1,000
| +2% | +$3.4K | ﹤0.01% | 2538 |
|
|
2019
Q4 | $240K | Sell |
51,193
-10,400
| -17% | -$42.6K | ﹤0.01% | 2487 |
|
|
2019
Q3 | $206K | Buy |
61,593
+1,650
| +3% | +$5.43K | ﹤0.01% | 2529 |
|
|
2019
Q2 | $197K | Buy |
59,943
+3,800
| +7% | +$11K | ﹤0.01% | 2512 |
|
|
2019
Q1 | $170K | Sell |
56,143
-3,500
| -6% | -$11.3K | ﹤0.01% | 2504 |
|
|
2018
Q4 | $162K | Sell |
59,643
-500
| -0.8% | -$1.65K | ﹤0.01% | 2389 |
|
|
2018
Q3 | $202K | Buy |
60,143
+270
| +0.5% | +$834 | ﹤0.01% | 2502 |
|
|
2018
Q2 | $154K | Sell |
59,873
-1,500
| -2% | -$3.73K | ﹤0.01% | 2532 |
|
|
2018
Q1 | $135K | Buy |
61,373
+2,000
| +3% | +$4.5K | ﹤0.01% | 2498 |
|
|
2017
Q4 | $118K | Buy |
59,373
+5,700
| +11% | +$12.4K | ﹤0.01% | 2492 |
|
|
2017
Q3 | $174K | Buy |
53,673
+4,350
| +9% | +$13.4K | ﹤0.01% | 2327 |
|
|
2017
Q2 | $159K | Buy |
49,323
+4,987
| +11% | +$14.1K | ﹤0.01% | 2302 |
|
|
2017
Q1 | $126K | Sell |
44,336
-1,294
| -3% | -$3.11K | ﹤0.01% | 2261 |
|
|
2016
Q4 | $106K | Buy |
45,630
+1,700
| +4% | +$3.24K | ﹤0.01% | 2187 |
|
|
2016
Q3 | $74K | Buy |
43,930
+530
| +1% | +$649 | ﹤0.01% | 2148 |
|
|
2016
Q2 | $46K | Hold |
43,400
| – | – | ﹤0.01% | 2163 |
|
|
2016
Q1 | $38K | Hold |
43,400
| – | – | ﹤0.01% | 2145 |
|
|
2015
Q4 | $53K | Buy |
43,400
+3,000
| +7% | +$4.17K | ﹤0.01% | 2097 |
|
|
2015
Q3 | $69K | Sell |
40,400
-7,000
| -15% | -$13.7K | ﹤0.01% | 2022 |
|
|
2015
Q2 | $99K | Sell |
47,400
-4,500
| -9% | -$10.9K | ﹤0.01% | 2071 |
|
|
2015
Q1 | $141K | Sell |
51,900
-56,000
| -52% | -$142K | ﹤0.01% | 2005 |
|
|
2014
Q4 | $277K | Buy |
107,900
+17,750
| +20% | +$39.9K | ﹤0.01% | 1616 |
|
|
2014
Q3 | $165K | Buy |
90,150
+10,750
| +14% | +$23.4K | ﹤0.01% | 1879 |
|
|
2014
Q2 | $212K | Sell |
79,400
-4,300
| -5% | -$12.9K | ﹤0.01% | 1788 |
|
|
2014
Q1 | $293K | Sell |
83,700
-6,250
| -7% | -$27.7K | ﹤0.01% | 1494 |
|
|
2013
Q4 | $402K | Buy |
89,950
+12,400
| +16% | +$50.5K | 0.01% | 1265 |
|
|
2013
Q3 | $315K | Buy |
77,550
+35,300
| +84% | +$154K | 0.01% | 1337 |
|
|
2013
Q2 | $176K | Buy |
+42,250
| New | +$163K | ﹤0.01% | 1596 |
|
Other funds holding ATRS
Commonwealth Equity Services's ATRS Position: Q2 2022 in Review
Commonwealth Equity Services sold out of Antares Pharma, Inc. (ATRS) in Q2 2022, closing a stake of 45,582 shares — an estimated $186K sold.
Commonwealth Equity Services first reported a position in ATRS in Q2 2013 and held it in 36 quarters. The position peaked at $402K in Q4 2013. 1 fund tracked by Wall St. Rank holds ATRS as of Q2 2022.
- Commonwealth Equity Services reported no remaining Antares Pharma, Inc. position as of Q2 2022 after selling out during the quarter.
- Commonwealth Equity Services sold 45,582 Antares Pharma, Inc. shares in Q2 2022, an estimated $186K.
- Commonwealth Equity Services first reported a position in Antares Pharma, Inc. in Q2 2013 and held it in 36 quarters.
- Commonwealth Equity Services's Antares Pharma, Inc. position peaked at $402K in Q4 2013.
- 1 fund tracked by Wall St. Rank held Antares Pharma, Inc. as of Q2 2022.
Based on Commonwealth Equity Services's 13F filing for Q2 2022, filed 19 Jul 2022.